Functional Expression of Low Density Lipoprotein Receptor-Related Protein Is Controlled by Receptor-Associated Protein in Vivo THOMAS E
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The VLDL Receptor Regulates Membrane Progesterone Receptor
© 2018. Published by The Company of Biologists Ltd | Journal of Cell Science (2018) 131, jcs212522. doi:10.1242/jcs.212522 RESEARCH ARTICLE The VLDL receptor regulates membrane progesterone receptor trafficking and non-genomic signaling Nancy Nader, Maya Dib, Raphael Courjaret, Rawad Hodeify, Raya Machaca, Johannes Graumann and Khaled Machaca* ABSTRACT the plasma membrane and interact with the classical P4 receptor, is Progesterone mediates its physiological functions through activation of nonetheless effective at mediating non-genomic P4 signaling both transcription-coupled nuclear receptors and seven-pass- (Bandyopadhyay et al., 1998; Dressing et al., 2011; Peluso et al., transmembrane progesterone receptors (mPRs), which transduce 2002). These results argued for the presence of membrane P4 the rapid non-genomic actions of progesterone by coupling to various receptors that are distinct from the nuclear P4 receptors. In 2003, the signaling modules. However, the immediate mechanisms of action Thomas laboratory identified a family of membrane progesterone downstream of mPRs remain in question. Herein, we use an untargeted receptors (mPRs) from fish ovaries (Zhu et al., 2003a,b) that belong quantitative proteomics approach to identify mPR interactors to better to the progestin and adiponectin (AdipoQ) receptor family (also define progesterone non-genomic signaling. Surprisingly, we identify named PAQ receptors). However, the signal transduction cascade the very-low-density lipoprotein receptor (VLDLR) as an mPRβ downstream of mPRs that mediates the non-genomic actions of P4 (PAQR8) partner that is required for mPRβ plasma membrane remains unclear. localization. Knocking down VLDLR abolishes non-genomic The non-genomic action of mPR and the ensuing signaling progesterone signaling, which is rescued by overexpressing VLDLR. -
Postprandial Lipid Metabolism: an Overview by RICHARD J
Proceedings of the Nutrition Society (1997), 56, 659466 659 Guest Lecture Postprandial lipid metabolism: an overview BY RICHARD J. HAVEL Cardiovascular Research Institute and Department of Medicine, University of California, San Francisco, California, USA Since the original investigations of Gage & Fish (1924) on the dynamics of large chylo- micron particles during postprandial lipaemia, measurements of triacylglycerol-rich lipo- proteins (TRL) after ingestion of fat-rich meals have been utilized to provide information about the metabolism of these intestinal lipoprotein particles in vivo. There are many similarities, however, between the metabolism of chylomicrons and hepatogenous VLDL (Havel, 1989), so that observations in the postprandial state may provide generally ap- plicable information about the regulation of TRL metabolism. Recently, it has become possible to distinguish the dynamics of chylomicron and VLDL particles separately by analysing the fluctuations of the concentrations of the two forms of apolipoprotein (apo) B with which they are associated B-48 and B-100 respectively (Havel, 1994). The overall pathway of absorption of dietary lipids has long been known and the rapid clearance and metabolism of chylomicron triacylglycerols was appreciated early in this century. The modern era of research in this area, however, had to await the development of methods to separate and characterize plasma lipoproteins (Gofman et al. 1949; Havel et af. 1955) and was greatly stimulated by the discovery of lipoprotein lipase (EC 3.1.1.34; Korn, 1955) and the demonstration that genetic deficiency of this enzyme dramatically reduces the rate of clearance of dietary fat from the blood (Havel & Gordon, 1960). Related physiological studies showed that chylomicron triacylglycerols are rapidly hydrolysed and that their products, free fatty acids (FFA), are concomitantly released and transported in the blood bound to albumin (Havel & Fredrickson, 1956). -
Apo E Structure Determines VLDL Clearance and Atherosclerosis Risk in Mice
Apo E structure determines VLDL clearance and atherosclerosis risk in mice Christopher Knouff, … , Patrick M. Sullivan, Nobuyo Maeda J Clin Invest. 1999;103(11):1579-1586. https://doi.org/10.1172/JCI6172. Article We have generated mice expressing the human apo E4 isoform in place of the endogenous murine apo E protein and have compared them with mice expressing the human apo E3 isoform. Plasma lipid and apolipoprotein levels in the mice expressing only the apo E4 isoform (4/4) did not differ significantly from those in mice with the apo E3 isoform (3/3) on chow and were equally elevated in response to increased lipid and cholesterol in their diet. However, on all diets tested, the 4/4 mice had approximately twice the amount of cholesterol, apo E, and apo B-48 in their VLDL as did 3/3 mice. The 4/4 VLDL competed with human LDL for binding to the human LDL receptor slightly better than 3/3 VLDL, but the VLDL clearance rate in 4/4 mice was half that in 3/3 mice. On an atherogenic diet, there was a trend toward greater atherosclerotic plaque size in 4/4 mice compared with 3/3 mice. These data, together with our earlier observations in wild- type and human APOE*2-replacement mice, demonstrate a direct and highly significant correlation between VLDL clearance rate and mean atherosclerotic plaque size. Therefore, differences solely in apo E protein structure are sufficient to cause alterations in VLDL residence time and atherosclerosis risk in mice. Find the latest version: https://jci.me/6172/pdf Apo E structure determines VLDL clearance and atherosclerosis risk in mice Christopher Knouff,1 Myron E. -
UNIVERSITY of CALIFORNIA, SAN DIEGO Intracellular and Extracellular Interactions of the Low Density Lipoprotein Receptor Related
UNIVERSITY OF CALIFORNIA, SAN DIEGO Intracellular and Extracellular Interactions of the Low Density Lipoprotein Receptor Related Protein (LRP-1) A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Chemistry by Miklos Guttman Committee in charge: Professor Elizabeth Komives, Chair Professor Tracy Handel Professor Kim Prather Professor Susan Taylor Professor Hector Viadiu-Ilarraza 2009 Copyright© Miklos Guttman, 2009 All rights reserved. The dissertation of Miklos Guttman is approved, and it is acceptable in quality and form for publication on microfilmand and electronically: ______________________________________________________ ______________________________________________________ ______________________________________________________ ______________________________________________________ ______________________________________________________ Chair University of California, San Diego 2009 iii TABLE OF CONTENTS Signature Page……………………………………………………................... iii Table of Contents……………………………………………………................ iv List of Symbols and Abbreviations……………………………..................... vi List of Figures…………………………………………………………………… ix List of Tables……………………………………..…………………………….. xi Acknowledgements…………………………….…………………….………… xii Vita, Publications, Fields of Study........……………… …………………….. xiv Abstract of the Dissertation…………………….…………………………….. xvi CHAPTER 1………………………………………………………………... 1 Introduction The LDL family of receptors…….………...….....……………………. 2 The LDL-receptor (LDLR)......…………..…… -
Apoer2/VLDL Receptor and Dab1 in the Rostral Migratory Stream Function in Postnatal Neuronal Migration Independently of Reelin
ApoER2/VLDL receptor and Dab1 in the rostral migratory stream function in postnatal neuronal migration independently of Reelin Nuno Andrade*, Vukoslav Komnenovic†, Sophia M. Blake*, Yves Jossin‡, Brian Howell§, Andre Goffinet‡, Wolfgang J. Schneider*, and Johannes Nimpf*¶ *Max F. Perutz Laboratories, University Departments at the Vienna Biocenter, Department of Medical Biochemistry, Medical University of Vienna, A-1030 Vienna, Austria; †Institute of Molecular Biotechnology, Austrian Academy of Sciences, 1030 Vienna, Austria; ‡Developmental Neurobiology Unit, University of Leuven Medical School, 3000 Leuven, Belgium; and §Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892 Edited by Thomas C. Su¨dhof, The University of Texas Southwestern Medical Center, Dallas, TX, and approved March 30, 2007 (received for review December 21, 2006) Postnatal migration of interneuron precursors from the subventricu- In the cerebrum, Reelin is crucial for correct positioning of lar zone to the olfactory bulb occurs in chains that form the substrate radially migrating neuroblasts via its binding to ApoER2 and for the rostral migratory stream. Reelin is suggested to induce de- very-low-density lipoprotein receptor (VLDLR) (18, 19), which tachment of neuroblasts from the chains when they arrive at the triggers tyrosine phosphorylation of the adaptor Dab1 by re- olfactory bulb. Here we show that ApoER2 and possibly very-low- ceptor clustering (20). Binding of Reelin to the receptors and density lipoprotein receptor (VLDLR) and their intracellular adapter subsequent phosphorylation of Dab1 are consecutive steps of a protein Dab1 are involved in chain formation most likely independent linear pathway, because disruption of any of the corresponding of Reelin. -
Handout 11 Lipoprotein Metabolism
Handout 11 Lipoprotein Metabolism ANSC/NUTR 618 LIPIDS & LIPID METABOLISM Lipoprotein Metabolism I. Chylomicrons (exogenous pathway) A. 83% triacylglycerol, 2% protein, 8% cholesterol plus cholesterol esters, 7% phospholipid (esp. phosphatidylcholine) B. Secreted as nascent chylomicrons from mucosal cells with ApoB48 and ApoA1 C. Acquire ApoC1, C2, and C3 in blood (from high-density lipoproteins) 1. ApoC1 activates lecithin:cholesterol acyltransferase (LCAT; in blood) and ApoC2 activates lipoprotein lipase. ApoC3 prevents uptake by the liver. 2. Required for conversion of chylomicrons to remnant particles. D. Triacylgycerols are removed from chylomicrons at extrahepatic tissues by lipoprotein lipase (LPL). E. Chylomicron remnants are taken up by the LDL-receptor-related protein (LRP). Exceptions: In birds, the lymphatic system is poorly developed. Instead, pro-microns are formed, which enter the hepatic portal system (like bile salts) and are transported directly to the liver. 1 Handout 11 Lipoprotein Metabolism Ruminants do not synthesis chylomicrons primarily due to low fat intake. Rather, their dietary fats are transported from the small intestine as very low-density lipoproteins. F. Lipoprotein lipase 1. Lipoprotein lipase is synthesized by various cells (e.g., adipose tissue, cardiac and skeletal muscle) and secreted to the capillary endothelial cells. a. LPL is bound to the endothelial cells by a heparin sulfate bond. b. LPL requires lipoproteins (i.e., apoC2) for activity, hence the name. 2. TAG within the chylomicrons and VLDL are hydrolyzed to NEFA, glycerol, and 2-MAG. a. NEFA and 2-MAG are taken up the tissues and reesterified to TAG b. Glycerol is taken up by the liver for metabolism and converted to G-3-P by glycerol kinase (not present in adipose tissue). -
Dissertation
DISSERTATION Titel der Dissertation Characterization of Thrombospondin-1 as novel ligand for the Reelin pathway receptors ApoER2 and VLDLR in the postnatal mouse brain angestrebter akademischer Grad Doktor/in der Naturwissenschaften (Dr. rer.nat.) Verfasserin / Verfasser: Sophia Maria Blake Matrikel-Nummer: 0021434 Dissertationsgebiet (lt. Stu- A 091490 Molekulare Biologie dienblatt): Betreuerin / Betreuer: Univ.-Prof. Dr. Johannes Nimpf Wien, am 06. Dezember 2008 Formular Nr.: A.04 Contents 1 Contents 1 Abstract .................................................................................... 3 2 Zusammenfassung .................................................................. 5 3 Introduction .............................................................................. 7 3.1 Neocortical development ..................................................................7 3.1.1 The Neocortex............................................................................. 7 3.1.2 Neuronal migration in the developing neocortex .................... 8 3.1.3 Cortical layering........................................................................ 10 3.1.4 Mouse strains with defects in cortical architecture............... 11 3.1.4.1 reeler................................................................................... 11 3.1.4.2 dab1-/- (scrambler, yotari) .................................................. 11 3.1.4.3 vldlr-/-/apoER2-/- .................................................................. 12 3.2 The Reelin signaling cascade........................................................ -
Postprandial Lipoprotein Metabolism: VLDL Vs Chylomicrons
UC Davis UC Davis Previously Published Works Title Postprandial lipoprotein metabolism: VLDL vs chylomicrons. Permalink https://escholarship.org/uc/item/9wx8p0x5 Journal Clinica chimica acta; international journal of clinical chemistry, 412(15-16) ISSN 0009-8981 Authors Nakajima, Katsuyuki Nakano, Takamitsu Tokita, Yoshiharu et al. Publication Date 2011-07-01 DOI 10.1016/j.cca.2011.04.018 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Clinica Chimica Acta 412 (2011) 1306–1318 Contents lists available at ScienceDirect Clinica Chimica Acta journal homepage: www.elsevier.com/locate/clinchim Invited critical review Postprandial lipoprotein metabolism: VLDL vs chylomicrons Katsuyuki Nakajima a,b,d,e,i,⁎, Takamitsu Nakano a,b, Yoshiharu Tokita a, Takeaki Nagamine a, Akihiro Inazu c, Junji Kobayashi d, Hiroshi Mabuchi d, Kimber L. Stanhope e, Peter J. Havel e, Mitsuyo Okazaki f,g, Masumi Ai h,i, Akira Tanaka g,i a School of Health Sciences, Faculty of Medicine, Gunma University, Maebashi, Gunma, Japan b Otsuka Pharmaceuticals Co., Ltd, Tokushima, Japan c Department of Laboratory Sciences, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan d Department of Lipidology and Division of Cardiology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan e Department of Molecular Biosciences, School of Veterinary Medicine and Department of Nutrition, University of California, Davis, CA, USA f Skylight Biotech Inc., Akita, Japan g Department of Vascular Medicine and -
And VLDL Receptor
International Journal of Molecular Sciences Review The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor Paula Dlugosz and Johannes Nimpf * Department of Medical Biochemistry, Max F. Perutz Laboratories, Medical University Vienna, 1030 Vienna, Austria; [email protected] * Correspondence: [email protected], Tel.: +43-1-4277-61808, Fax: +43-1-4277-9618 Received: 28 August 2018; Accepted: 3 October 2018; Published: 9 October 2018 Abstract: Apolipoprotein E receptor 2 (ApoER2) and VLDL receptor belong to the low density lipoprotein receptor family and bind apolipoprotein E. These receptors interact with the clathrin machinery to mediate endocytosis of macromolecules but also interact with other adapter proteins to perform as signal transduction receptors. The best characterized signaling pathway in which ApoER2 and VLDL receptor (VLDLR) are involved is the Reelin pathway. This pathway plays a pivotal role in the development of laminated structures of the brain and in synaptic plasticity of the adult brain. Since Reelin and apolipoprotein E, are ligands of ApoER2 and VLDLR, these receptors are of interest with respect to Alzheimer’s disease. We will focus this review on the complex structure of ApoER2 and VLDLR and a recently characterized ligand, namely clusterin. Keywords: apolipoprotein E receptor 2; VLDL receptor; reelin; clusterin; Alzheimer’s disease 1. Introduction Apolipoprotein E receptor 2 (ApoER2) and VLDL receptor (VLDLR) belong to the low density lipoprotein receptor (LDLR) family, a class of type-I transmembrane receptors with high homology to their name-giving member the LDL receptor. Besides more distant members of this family, such as LRP 1, 1b, 2, 5, and 6; ApoER2, VLDLR, and LDLR have a superimposable structure indicating that the corresponding genes may have evolved from one single ancestor by gene duplication events and minor exon rearrangements. -
Apolipoprotein E4 Exaggerates Diabetic Dyslipidemia and Atherosclerosis in Mice Lacking the LDL Receptor Lance A
ORIGINAL ARTICLE Apolipoprotein E4 Exaggerates Diabetic Dyslipidemia and Atherosclerosis in Mice Lacking the LDL Receptor Lance A. Johnson, Jose M. Arbones-Mainar, Raymond G. Fox, Avani A. Pendse, Michael K. Altenburg, Hyung-Suk Kim, and Nobuyo Maeda OBJECTIVE—We investigated the differential roles of apolipo- circulation and a major determinant of plasma cholesterol protein E (apoE) isoforms in modulating diabetic dyslipidemia— and CVD risk (3). In humans, the APOE gene is polymorphic, a potential cause of the increased cardiovascular disease risk of resulting in production of three common isoforms: apoE2, patients with diabetes. apoE3, and apoE4. The apoE4 isoform is carried by more than a quarter (28%) of the U.S. population and is associ- RESEARCH DESIGN AND METHODS—Diabetes was induced using streptozotocin (STZ) in human apoE3 (E3) or human apoE4 ated with higher LDL cholesterol and an increased risk of (E4) mice deficient in the LDL receptor (LDLR2/2). CVD (3). In addition to its well-established role in CVD, recent findings have implicated a role for apoE in glucose 2/2 2/2 RESULTS—Diabetic E3LDLR and E4LDLR mice have in- metabolism. Epidemiological studies have suggested that distinguishable levels of plasma glucose and insulin. Despite this, in certain populations, APOE genotype may influence diabetes increased VLDL triglycerides and LDL cholesterol in 2 2 2 2 plasma glucose and insulin levels (4,5), postprandial glu- E4LDLR / mice twice as much as in E3LDLR / mice. Diabetic E4LDLR2/2 mice had similar lipoprotein fractional catabolic cose response (6), the development of metabolic syn- rates compared with diabetic E3LDLR2/2 mice but had larger drome (7,8), and a myriad of diabetes complications (9). -
Metabolic Fate of Chylomicron Phospholipids and Apoproteins in the Rat
Metabolic Fate of Chylomicron Phospholipids and Apoproteins in the Rat Alan R. Tall, … , Robert M. Glickman, John W. Riley J Clin Invest. 1979;64(4):977-989. https://doi.org/10.1172/JCI109564. Research Article To study the metabolic fate of chylomicron phospholipid and apoproteins, 15 mg of doubly labeled (3[H]leu, [32P]phospholipid) rat mesenteric lymph chylomicrons were injected as an intravenous bolus into conscious rats. The specific radioactivity, composition, pool size, and morphology of the plasma lipoproteins were determined after 2-60 min. After injection of chylomicrons, there was a rapid transfer of radioactivity into high density lipoproteins (HDL). At peak specific activity in HDL (2-5 min), 35% of injected apoprotein and 25% of phospholipid radioactivity were recovered in HDL (d 1.063-1.21 g/ml), with smaller recoveries in other lipoproteins and liver. There was an initial rapid rise of3 2P specific activity in HDL and d 1.02-1.063 lipoproteins (low density lipoproteins [LDL]), but whereas LDL specific activity subsequently converged with that of d < 1.02 lipoproteins, HDL specific activity decayed more rapidly than LDL ord < 1.02 lipoproteins. Lipolysis of chylomicrons was associated with a transfer of phospholipid mass into LDL and HDL. At 5 min, 80% of injected triglyceride had been lipolyzed and there was a significant increase in phospholipid mass in LDL and a smaller increase in HDL. At 10 min, the mass of phospholipid in LDL had returned towards control values, and there was a further increase in phospholipid mass in HDL, which suggested phospholipid transfer from LDL to HDL. -
LIS1 and Dynein Motor Function in Neuronal Migration and Development
Downloaded from genesdev.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW LIS1 and dynein motor function in neuronal migration and development Anthony Wynshaw-Boris1 and Michael J. Gambello Departments of Pediatrics and Medicine, University of California, San Diego, School of Medicine, La Jolla, California 92093-0627, USA Neuronal migration has been studied extensively for led to the elucidation of a RELN-dependent signal trans- over 30 years in diverse mammalian species from the duction pathway (for recent review, see Rice and Curran mouse to human. The sequence of events that occurs 1999). Other genes have been identified that are respon- during cortical development is shared by all of these spe- sible for neuronal migration defects in the human (LIS1 cies (for reviews, see Gleeson and Walsh 2000; Walsh and and DCX) and mouse (Cdk5 and its required activators Goffinet 2000). At the time of neurogenesis, neural pre- p35 and p39), but until recently, the relationship be- cursors proliferate and differentiate into young postmi- tween these genes involved in migration were unknown. totic neurons. These postmitotic immature neurons mi- Several recent studies have demonstrated that LIS1, grate from the ventricular zone (VZ) to a layer called the the protein product of a gene mutated in the human neu- preplate at the surface of the developing cerebral cortex. ronal migration defect lissencephaly, binds to and regu- The first migrating neurons split the preplate and form lates dynein motor function in the cell. These studies the cortical plate, which develops into the cortex. As place LIS1 in the midst of a well-studied motor complex migration from the VZ continues, cortical lamination is important for several critical cell functions and perhaps established in an inside-out fashion.